ACTRN12620000870954进行中（未招募）3 期
Evaluating the efficacy and cost-effectiveness of stem cell injections in people with mild to moderate knee osteoarthritis: a randomised placebo-controlled trial (The SCUlpTOR trial)
适应症
试验速览
- 阶段
- 3 期
- 状态
- 进行中（未招募）
- 入组人数
- 321
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 40 Years 至 o limit（—）
- 性别
- All
入选标准
- •Ability and willingness to participate and complete the study
- •Having internet access and an active email account
- •Having functional English
- •Australian Citizen or Permanent resident
- •People >=40 years of age
- •Knee OA as defined by the clinical and radiographic American College of Rheumatology (ACR) criteria
- •Presence of pain in the study knee for at least half of the days in the previous month
- •Average pain intensity >= 40 and <= 90 on a 0-100 visual analogue scale (VAS) over the past week before the Online Screening and Baseline surveys
- •Kellgren-Lawrence grade (KLG) 2 or 3 of the study knee based on knee radiographs
- •Medial or lateral minimal joint space width (mJSW) between 0.5 and 4 mm of the study knee based on radiographs
- •Willingness to undergo a new knee X-ray and MRI
- •Willingness to stop or maintain a routine (on the same dosage and frequency) of conservative treatments
- •Willingness to stop or minimise the use of anti-inflammatory drugs and other analgesics (except paracetamol for rescue pain relief) for the duration of the study
- •Willingness to undergo a 1-week medication wash-out (for all pain medications) before each pain assessment (baseline, 3, 6, 9, 12, 15, 18, 21 and 24-months).
- •Willingness to avoid a new treatment for knee OA during the study
- •Willingness and ability to travel for study visits according to their site
排除标准
- •Incomplete online screening surveys
- •Participants that are non-responders after completing the screening survey but before being enrolled
- •Women who are pregnant or breastfeeding, or women of childbearing potential not willing to use contraceptive methods for the duration of the study
- •Bilateral symptomatic knee OA if the patient-reported pain intensity in the contralateral knee is >= 30 on a 0-100 VAS
- •Significant injury in the study knee that led to substantial loss of function or surgeries within the past 6 months
- •Prior knee joint replacement or high tibial osteotomy in the study knee
- •Surgery on the study knee within the past 12 months
- •Planned surgery for the study knee in the next 24 months
- •History of crystalline arthropathy, autoimmune arthritis, hemochromatosis or fibromyalgia. Except for the following conditions:
- •i. participants diagnosed with gout are eligible for the study as long as the condition is being appropriately treated and they have not experienced flare-ups for at least 12 months
- •ii. participants diagnosed with hemochromatosis but with normal iron levels for at least 12 months are eligible for the study
- •Signs of acute knee joint inflammation (i.e., red, swollen and hot) and/or abnormal synovial fluid suggestive of either crystal or infection;
- •Any painful muscular or neurological condition of the lower limb that, in the opinion of the investigators, is the main contributor to the pain and/or loss of function in the study knee which may interfere with the self-reported assessment
- •Immunosuppression or acute infective processes
- •Cancer or other tumour-like lesions, except for non-melanoma skin cancer which has been removed and not active within the past 3 years
- •Hyaluronic acid (HA) injection within the past 6 months
- •Autologous blood product or stem cell injection in the study knee within the past 12 months
- •Steroid injections in any joint within the past 6 months
- •Regularly taking centrally acting analgesics (e.g., opioid analgesics, duloxetine and pregabalin)
- •Participation in another clinical trial and/or treatment received with any investigational agent within 30 days before enrolment
- •Any unstable concurrent clinically significant acute, chronic medical conditions or abnormal laboratory findings that, in the judgment of the Investigator, would jeopardise the safety of the participant, interfere with study objectives or affect the participant’s compliance
- •Needle phobia
- •Contraindications to MRI
- •Inability to fit into the MRI knee coil
研究者
相似试验
已完成
不适用
The evaluation of rapid methicillin-resistant Staphylococcus aureus (MRSA) screeningStaphylococcus aureus infectionMethicillin-resistant Staphylococcus aureus (MRSA) colonisation and infectionInfections and InfestationsISRCTN84432505Department of Health (UK)12,000
进行中（未招募）
不适用
Evaluation of the effectiveness and cost-effectiveness of functional foods in glycemic controlCost-Efficiency AnalysisEfficiencyG07.203.300.572Diabetes MellitusRBR-9qmsphtFundação Osvaldo Cruz
进行中（未招募）
Unknown
Effectiveness and cost-effectiveness study of the Liaison Mental Health-Education Program for schoolsChild and adolescent mental health disordersMental and Behavioural DisordersISRCTN15214459Instituto de Psiquiatria y Salud Mental, Hospital Gregorio Marañón15,000
尚未招募
不适用
Evaluating the clinical and cost-effectiveness of a combined person-centred intervention of Advance Care Planning (ACP) and care coordination for people with Parkinson’s disease and their family caregiver(s)Parkinson’s disease and ParkinsonismsNL-OMON26859Radboud university medical center, Nijmegen, the Netherlands176
进行中（未招募）
4 期
Multicentre evaluation of sodium bicarbonate in acute kidney injury in critical care (MOSAICC)ISRCTN14027629niversity Hospitals of Derby and Burton NHS Foundation Trust2,250